Company profilePharmaceutical#114 of 1,318 in Pakistan1 DRAP alert

S.J & G. Fazul Ellahie (pvt) limited.

Pharmaceutical company · 140 brands · 233 molecules

Ranked #44 of 213 companies in Other Beta-Lactam, Cephalosporins & Penems

140 registered products 42 pharmaceutical brands 233 distinct molecules 1 DRAP alert

Company overview

140
registered products
42
pharmaceutical brands
233
distinct molecules
12
therapeutic classes
1
DRAP alerts

S.J & G. Fazul Ellahie (pvt) limited. is a pharmaceutical manufacturer registered with the Drug Regulatory Authority of Pakistan, holding 140 product registrations across 233 distinct molecules. It is the 114th largest registrant in Pakistan by product count, and ranks 44th of 213 in Other Beta-Lactam, Cephalosporins & Penems. Its portfolio is concentrated in Other Beta-Lactam, Cephalosporins & Penems and Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord). DRAP has issued 1 alert involving its products.

Compiled from the DRAP registry, DRAP approved prices and DRAP alerts, with observed retail from DVAGO and Servaid. Data as of 2026-07-30.

Products by S.J

205 products matched in our catalogue · showing 80 — each with its observed price and DRAP approved ceiling.

Price ceiling age

DRAP sets a maximum price per registration and revises it only on application. In a market with high inflation, an old ceiling erodes margin in real terms.

141
ceilings with an approval date
1
not revised in 2+ years
2024
oldest approval year
20241
2025140
Longest without revision

Top molecules by brand count

Pyridoxine5 brands
Thiamine5 brands
Nicotinamide4 brands
Riboflavin4 brands
Glucosamine4 brands
Mebeverine3 brands
Kanamycin3 brands
Omeprazole3 brands

Therapeutic classes

Other Beta-Lactam, Cephalosporins & Penems · 6Drugs For Peptic Ulcer And Gastro-Oesophageal Reflux Disease (Gord) · 6Gastro · 5Pain Management · 5Drugs For Treatment Of Bone Diseases · 4Antiinflammatory And Antirheumatic Products · 4Quinolone Antibacterials · 3Antispasmodic & Anticholinergic · 3Anti-Infectives · 3Tonic · 2Neuro · 2Other Anti-Baterials · 2

Conditions treated

Ulcer/Reflux/Flatulence/Acidity · 3General Infections · 3Muscle Relaxant/Spasm · 2Arthritis · 2Neuropathic Pain/Epilepsy/Convulsion · 1Gout · 1Digestion · 1Anxiety/Depression/Insomnia · 1Vomiting/Emesis · 1Eczema/Psoriasis/Dermatitis · 1Pain Killers · 1

Price band (DRAP official ceilings)

Registered products priced by source
DRAP-official132 products · Rs 15.42 – Rs 30,266.18
DVAGO38 products · Rs 12.57 – Rs 16,849.68
Servaid25 products · Rs 159 – Rs 1,343.4
Median across source: Rs 360.22

Regulatory record

1 alert in the DRAP feed we track.

Drug Product Recall: Nyloz Capsule (Batch # C01358) by M/s Zephyr Pharmatec, Karachi and m
2021-08-09

Competitive set

Companies whose registered portfolio overlaps most with this one.

Portfolio whitespace

Molecules the closest competitors have registered and this company has not — the starting point for a launch shortlist.

Wilshire Laboratories (Private) Limited holds 83 molecules not in this portfolio
AcyclovirAcyclovir SodiumAmlodipineAmoxicillinAmoxycillinAmoxycillin Base
NABIQASIM INDUSTRIES (PVT) LTD. holds 145 molecules not in this portfolio
2 MiuAcefyllin PiperazineAcefyllineAcetaminophinAcetylsalicyclic AcidAcyclovir
BIO LABS (PVT) LTD. holds 96 molecules not in this portfolio
000 I.UAmlodipineAremetherAscorbic AcidAzathioprineAzithromycin 250Mg

Get the full profile for S.J

This page is a summary. The full company brief adds every registration with its approved ceiling and approval date, per-molecule competitive position, price positioning against the category, and a launch shortlist built from the whitespace above.

Request this brief See what’s included

Company data as of 2026-07-30. Brand and molecule counts from the DRAP registry and observed retail sources.

For medicine intelligence and professional reference only. Not medical advice.